📈 Jumpstart Signal Watchlist — October 21, 2026

🏢 What they do: OneSpan provides cybersecurity and digital agreement solutions, including identity verification, authentication, fraud prevention, and mobile app security. Its digital agreement products support secure e-signatures, online notarization, and automated document workflows.
- 🎯 Current $18.87 is 7% below 3yr high $20.23 · ⏳ SMA200 $13.78 (current price $18.87 is above) · 💰 Market Cap $694M
- OSPN shows decent technicals supported by positive sentiment.

💎 Quality (Q): 40/60
- 🏦 Base breakout (range: 5.7%); Low drawdown (14.3% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; ROE 25% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 2/20
- 🔔 Strong above EMA21 (5.6%)
- 📈 RSI at 63 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive (✅×3).
✅ OneSpan Advances DigipassONE to Help Organizations Put Modern Authentication into Practice — Yahoo Finance.
🤖 OneSpan previewed a passkey free trial and shared progress on DigipassONE Verify, with general availability expected in early 2027. The product developments could strengthen its authentication offering; the article is dated October 19, though the search result notes it was updated October 22.
✅ OneSpan Inc. (OSPN) Discusses Innovations Extending E-Signature Across Digital Agreement Workflows — Seeking Alpha.
🤖 The October 14 discussion covered innovations extending e-signature into broader digital agreement workflows, including capabilities intended to reduce manual work and improve security. This supports the company’s product expansion, though the discussion includes a mix of available features, early-access innovations, and future product direction.
✅ OneSpan expands digital agreements platform beyond e-signature — Investing.com.
🤖 OneSpan announced new and planned digital-agreement capabilities, including AI-assisted document preparation, automated validation, and biometric identity verification. The expansion may broaden the platform’s value to financial institutions and other customers handling high-value transactions.
🍭 Bonus (B): 10/10 — Computer Integrated Systems Design (Technology sector)

🏢 What they do: Paysign, Inc. is a payments technology company that provides prepaid card programs, integrated payment processing, and digital banking/payment solutions for businesses, healthcare and pharmaceutical clients, and government or consumer payout programs.
- 🎯 At/above 3yr high $15.62 (current $15.62) · ⏳ SMA200 $7.96 (current price $15.62 is above) · 💰 Market Cap $882M
- PAYS passed all filters and shows favorable conditions.

💎 Quality (Q): 53/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 450% (>20%); Revenue growth 48% (>15%); ROE 26% (>15%); Low LT D/E 0.06 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (7.2%)
- 🔔 Strong above EMA50 (17.2%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 63 showing strength
📢 Sentiment (S): 5/10
- 🗞️ News sentiment is neutral (⚪️×1).
⚪️ Paysign CEO Mark Newcomer sells $766,895 of PAYS stock — Investing.com.
🤖 CEO Mark Newcomer sold 50,000 shares under a previously adopted Rule 10b5-1 trading plan. This is an insider transaction, but by itself does not establish a directional catalyst for the stock.
🍭 Bonus (B): 0/10 — Business Services

🏢 What they do: Aveanna Healthcare provides in-home nursing and therapy, home health and hospice care, and medical supplies such as enteral nutrition products. Its services support children and adults with complex medical needs.
- 🎯 Current $12.99 is 10% below 3yr high $14.38 · ⏳ SMA200 $9.12 (current price $12.99 is above) · 💰 Market Cap $2.8B
- AVAH shows decent technicals supported by positive sentiment.

💎 Quality (Q): 43/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 38% (>20%); ROE 96% (>15%); Near-high ROE setup (52wk high + ROE); PEG ratio 0.27 (<1.5).
⏰ Entry (E): 4/20
- ⚠️ SMA20/SMA50 bearish crossover
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive (✅×3 ⚪️×1; showing 3 of 4).
✅ Raymond James initiates Aveanna Healthcare stock coverage with Strong Buy — Investing.com.
🤖 Raymond James initiated coverage with a Strong Buy rating and a $15 price target, implying about 21% upside from the price cited in the article. The article also notes Aveanna’s second-quarter revenue beat and raised full-year outlook.
✅ Aveanna Healthcare Holdings Inc. (AVAH) Stock Has Average Target Price of $14.06 According to Analysts — MarketBeat.
🤖 The article reports an average analyst price target of $14.06, above the share price cited. That suggests analysts see potential upside, though the target is a consensus measure rather than a new company catalyst.
⚪️ Aveanna Healthcare Holdings (AVAH) Stock Could Be Cheap On Earnings — Yahoo Finance.
🤖 The article discusses Aveanna’s valuation relative to earnings after a strong multi-year share-price run. It does not report a new company-specific catalyst or a clear directional analyst rating.
🍭 Bonus (B): 0/10 — Home Health Care Services

🏢 What they do: Red Violet, Inc. provides identity intelligence software and data solutions for identity verification, fraud detection and prevention, risk mitigation, investigations, due diligence, customer acquisition, and asset recovery. Its products include idiCORE and FOREWARN.
- 🎯 Current $78.56 is 2% below 3yr high $80.25 · ⏳ SMA200 $56.20 (current price $78.56 is above) · 💰 Market Cap $1.1B
- RDVT shows decent technicals supported by positive sentiment.

💎 Quality (Q): 54/60
- 🏦 Low drawdown (13.3% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 89% (>20%); Revenue growth 23% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 0/20
- 📈 RSI at 55 in healthy mid-range
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive (✅×3 ⚪️×2; showing 4 of 5).
✅ Red Violet (NASDAQ:RDVT) Stock Rating Upgraded by Wall Street Zen — MarketBeat.
🤖 Wall Street Zen upgraded Red Violet from “hold” to “buy,” adding to the positive analyst outlook for the stock.
✅ Red Violet股價創歷史新高，報80.39美元 — Investing.com.
🤖 The article reports that Red Violet shares reached a record high and cites strong second-quarter results that exceeded expectations, including 23% year-over-year revenue growth. It also notes positive analyst coverage.
⚪️ Red Violet (NASDAQ:RDVT) Sees Large Volume Increase - What's Next? — MarketBeat.
🤖 The article reports increased trading volume and recaps analyst ratings, including a Wall Street Zen upgrade. It does not identify a new company-specific operating catalyst.
⚪️ 3 RegTech Stocks Investors May Be Watching After Bank Of America’s $1.2b Penalty — Yahoo Finance.
🤖 The article mentions Red Violet as a company whose identity-intelligence tools serve financial compliance and fraud-prevention needs, but it does not report a new company-specific catalyst.
🍭 Bonus (B): 10/10 — Prepackaged Software (Technology sector)

🏢 What they do: CareDx, Inc. is a precision medicine company focused on transplant patients. It develops diagnostics, digital health tools, lab products, and patient support services to help monitor care before and after organ transplantation.
- 🎯 At/above 3yr high $70.74 (current $70.74) · ⏳ SMA200 $31.73 (current price $70.74 is above) · 💰 Market Cap $3.6B
- CDNA shows decent technicals supported by positive sentiment.

💎 Quality (Q): 59/60
- 🏦 Low drawdown (12.2% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 1394% (>20%); Revenue growth 52% (>15%); ROE 26% (>15%).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (10.8%)
- 🔔 Strong above EMA50 (24.6%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 68 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive (✅×4; showing 3 of 4).
✅ CareDx (NASDAQ:CDNA) Stock Price Target Raised at ... — MarketBeat.
🤖 Canaccord Genuity raised its price target for CareDx from $65 to $80, a favorable analyst revision. The article also notes BTIG’s earlier price-target increase and Buy rating.
✅ CareDx (NASDAQ:CDNA) Hits New 1-Year High — MarketBeat.
🤖 CareDx shares reached a new 52-week high, and the article reports quarterly results that beat analyst expectations for EPS and revenue. The share-price milestone is positive, though the article also notes the consensus analyst rating remains Hold.
✅ CareDx Inc株価が52週高値72.61ドルを記録 — Investing.com.
🤖 The article reports a 52-week share-price high and favorable analyst developments, including BTIG maintaining Buy while raising its price target and Canaccord initiating coverage with Buy. It also notes H.C. Wainwright maintained a Neutral rating.
🍭 Bonus (B): 0/10 — Medical Laboratories

🏢 What they do: Worthington Enterprises designs and manufactures building and consumer products, including HVAC and water systems, metal roofing and ceiling components, tools, portable propane and helium cylinders, outdoor-living products, and celebration supplies. Its brands include Bernzomatic, Balloon Time, Coleman propane cylinders, Garden Weasel, and LEVEL5 Tools.
- 🎯 Current $65.10 is 3% below 3yr high $67.39 · ⏳ SMA200 $55.96 (current price $65.10 is above) · 💰 Market Cap $3.2B
- WOR shows decent technicals supported by positive sentiment.

💎 Quality (Q): 57/60
- 🏦 Low drawdown (14.2% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 24% (>20%); ROE 16% (>15%); Low LT D/E 0.29 (<1.0).
⏰ Entry (E): 3/20
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 64 showing strength
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive (✅×3 ⚪️×1; showing 3 of 4).
✅ Worthington Enterprises (WOR): Could A Handful Of Steel Tanks Redefine This Industrial Stock? — Yahoo Finance.
🤖 The article highlights $13 million in quarterly revenue from engineered tanks used in data-center liquid cooling, matching the product line’s fiscal 2026 revenue, alongside higher sales and free cash flow. It also notes margin pressure in a segment, tempering the otherwise favorable growth picture.
✅ Worthington Enterprises Shares Jump 15% on Strong Earnings and Cash Flow Boost — Yahoo Finance.
🤖 The article reports fiscal first-quarter revenue growth of 13%, adjusted EBITDA growth of 10%, and nearly doubled free cash flow, with demand for data-center cooling tanks also noted. These results and cash generation support a positive assessment.
⚪️ Worthington Enterprises director John McConnell sells $4.17m in stock — Investing.com.
🤖 The article reports that director John McConnell sold shares after exercising an equal number of stock options. This is a reported insider transaction, not by itself evidence of a change in the company’s outlook.
🍭 Bonus (B): 0/10 — Steel Works & Blast Furnaces

🏢 What they do: IDT Corporation provides communications and payment services, including international money transfers, prepaid calling and digital payment products, and wholesale voice and messaging. It also offers point-of-sale and payment-processing tools for independent retailers and cloud-based communications services for businesses.
- 🎯 Current $82.94 is 2% below 3yr high $84.46 · ⏳ SMA200 $58.31 (current price $82.94 is above) · 💰 Market Cap $2.1B
- IDT shows decent technicals supported by positive sentiment.

💎 Quality (Q): 56/60
- 🏦 Low drawdown (6.8% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 28% (>20%); ROE 23% (>15%); Low LT D/E 0.02 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (5.0%)
- 🔔 Strong above EMA50 (12.4%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 67 showing strength
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive (✅×3 ⚪️×2; showing 4 of 5).
✅ IDT Q4 Earnings and Revenues Rise as Margins Expand on Strong Growth — Zacks.
🤖 IDT reported higher fourth-quarter earnings, with GAAP EPS up 29.9% and non-GAAP EPS up 23.7% year over year. The results point to earnings growth and expanding margins.
✅ IDT (NYSE:IDT) Hits New 1-Year High - What's Next? — MarketBeat.
🤖 The article reports IDT reaching a new one-year high and notes analyst actions including Freedom Broker raising its price target to $85 with a Buy rating. It also mentions quarterly EPS missed consensus, a counterpoint to the positive price and analyst signals.
⚪️ IDT (NYSE:IDT) Stock: Insider Menachem Ash Sells 5,000 Shares — MarketBeat.
🤖 The article reports an executive’s share sale, a disclosed insider transaction rather than a change in the company’s outlook. It also recaps analyst rating changes, including a Buy upgrade and a higher price target.
⚪️ IDT CFO Marcelo Fischer sells $760,847 in class B common stock — Investing.com.
🤖 The article reports the CFO’s sale of Class B shares, which is an insider transaction and not by itself evidence of a change in business fundamentals. It also recaps strong fiscal 2026 results and record margins.
🍭 Bonus (B): 0/10 — Telephone Communications

🏢 What they do: GigaCloud Technology Inc. (GCT) operates a B2B e-commerce marketplace specializing in large-parcel merchandise like furniture, appliances, and fitness equipment. It provides an end-to-end platform that connects manufacturers (primarily in Asia) with retailers in markets such as the US and Europe, handling product sourcing, logistics, global fulfillment across 39 facilities, sales, and delivery.
- 🎯 At/above 3yr high $60.39 (current $60.39) · ⏳ SMA200 $43.40 (current price $60.39 is above) · 💰 Market Cap $563M
- GCT shows decent technicals supported by positive sentiment.

💎 Quality (Q): 53/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 27% (>20%); Revenue growth 28% (>15%); ROE 29% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (7.5%)
- 🔔 Strong above EMA50 (14.6%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 69 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive (✅×5; showing 3 of 5).
✅ GigaCloud Technology (NASDAQ:GCT) Hits New 12- ... — MarketBeat.
🤖 The article reports GigaCloud shares reached a new 52-week high and notes recent analyst upgrades to Strong Buy. The share-price milestone and improved ratings are positive signals, though the article also mentions an insider sale.
✅ GigaCloud Technology stock hits 52-week high at 58.27 USD — Investing.com.
🤖 GigaCloud reached a 52-week high. The article also recaps stronger-than-expected second-quarter results and a newly approved $120 million buyback, both supportive of the stock.
✅ GigaCloud Technology (NASDAQ:GCT) Hits New 52-Week High Following Analyst Upgrade — MarketBeat.
🤖 The article links a new 52-week high with Wall Street Zen's upgrade to Strong Buy. It also cites quarterly results that exceeded analyst expectations.
🍭 Bonus (B): 0/10 — Catalog & Mail-Order